Breakthrough COPD Treatment Awaits FDA Approval Promising Major Market Impact

COPD

Verona Pharma is poised for a pivotal breakthrough with its drug candidate, ensifentrine, potentially transforming COPD treatment pending an …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave